⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for cd226 agonist

Every month we try and update this database with for cd226 agonist cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of LY3435151 in Participants With Solid TumorsNCT04099277
Solid Tumor
Triple-negative...
Gastric Adenoca...
Head and Neck S...
Cervical Carcin...
High Grade Sero...
Hepatocellular ...
Undifferentiate...
Leiomyosarcoma
LY3435151
Pembrolizumab
18 Years - Eli Lilly and Company
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: